Although it is quite conceivable that the transfer of cGMP may contribute to the antifibrotic and antihypertrophic CF/CMF-to-CM cross-talk within the Ang II challenged heart, this hypothesis awaits experimental confirmation. The gene discussed is AGT; the disease is cystic fibrosis.